IL94869A - Preparations used as pregnancy motors in males containing melatonin and androgen - Google Patents

Preparations used as pregnancy motors in males containing melatonin and androgen

Info

Publication number
IL94869A
IL94869A IL9486990A IL9486990A IL94869A IL 94869 A IL94869 A IL 94869A IL 9486990 A IL9486990 A IL 9486990A IL 9486990 A IL9486990 A IL 9486990A IL 94869 A IL94869 A IL 94869A
Authority
IL
Israel
Prior art keywords
melatonin
androgen
composition
accordance
testosterone
Prior art date
Application number
IL9486990A
Other languages
English (en)
Hebrew (he)
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of IL94869A publication Critical patent/IL94869A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9486990A 1989-06-27 1990-06-26 Preparations used as pregnancy motors in males containing melatonin and androgen IL94869A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37179489A 1989-06-27 1989-06-27

Publications (1)

Publication Number Publication Date
IL94869A true IL94869A (en) 1994-10-07

Family

ID=23465430

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9486990A IL94869A (en) 1989-06-27 1990-06-26 Preparations used as pregnancy motors in males containing melatonin and androgen

Country Status (17)

Country Link
EP (1) EP0479867B1 (fr)
JP (1) JPH07507037A (fr)
CN (1) CN1048327A (fr)
AR (1) AR246870A1 (fr)
AT (1) ATE137970T1 (fr)
AU (1) AU639467B2 (fr)
CA (1) CA2059138A1 (fr)
DD (2) DD299619A5 (fr)
DE (1) DE69027028T2 (fr)
EG (1) EG19390A (fr)
GR (1) GR1002142B (fr)
IL (1) IL94869A (fr)
IN (1) IN171596B (fr)
NZ (1) NZ234210A (fr)
PT (1) PT94493A (fr)
WO (1) WO1991000095A1 (fr)
ZA (1) ZA905020B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105240A (en) * 1992-04-07 1999-04-11 Neurim Pharma 1991 The use of melatonin in the preparation of a drug for the treatment of benign prostatic hyperplasia
US5401669A (en) * 1993-05-13 1995-03-28 Memc Electronic Materials, Spa Process for the preparation of silicon wafers having controlled distribution of oxygen precipitate nucleation centers
WO1996040150A1 (fr) * 1995-06-07 1996-12-19 Merck & Co., Inc. Traitement et prevention de maladies prostatiques
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
GB9813278D0 (en) * 1998-06-20 1998-08-19 Medical Res Council Male contraceptive
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
US6119870A (en) * 1998-09-09 2000-09-19 Aec Oil Sands, L.P. Cycloseparator for removal of coarse solids from conditioned oil sand slurries
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Also Published As

Publication number Publication date
EP0479867B1 (fr) 1996-05-15
GR900100489A (el) 1991-11-15
CA2059138A1 (fr) 1990-12-28
ATE137970T1 (de) 1996-06-15
DE69027028D1 (de) 1996-06-20
AR246870A1 (es) 1994-10-31
PT94493A (pt) 1991-02-08
CN1048327A (zh) 1991-01-09
EP0479867A1 (fr) 1992-04-15
WO1991000095A1 (fr) 1991-01-10
AU639467B2 (en) 1993-07-29
DD299619A5 (de) 1992-04-30
GR1002142B (en) 1996-02-15
NZ234210A (en) 1994-10-26
IN171596B (fr) 1992-11-21
DE69027028T2 (de) 1996-09-26
ZA905020B (en) 1991-04-24
JPH07507037A (ja) 1995-08-03
AU5968390A (en) 1991-01-17
EG19390A (en) 1995-01-31
DD297327A5 (de) 1992-01-09

Similar Documents

Publication Publication Date Title
EP0354921B1 (fr) Utilisation de la mélatonine pour la fabrication d'une composition contraceptive
CZ288062B6 (cs) Přípravek pro ženskou antikoncepci
EP0479867B1 (fr) Preparations utiles comme contraceptifs chez l'homme
CA2056364C (fr) Compositions et methodes pour la contraception
CA2100086C (fr) Compositions et methodes pour soulager les symptomes de la menopause
AU644367B2 (en) Use of melatonin derivatives for effecting contraception
Segal Contraceptives for the Twenty-First Century
IL94411A (en) Compositions comprising an analog of melatonin in combination with progestogen and/or estrogen for effecting contraception
NZ244997A (en) Use of melatonin derivatives for contraception
IL96926A (en) Pharmaceutical compositions for alleviating post-menopausal symptoms comprising melatonin and a least one estrogen and/ or androgen

Legal Events

Date Code Title Description
RH Patent void